ID   GYRB_ECOLI              Reviewed;         804 AA.
AC   P0AES6; O08438; P06982; Q2M811;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   22-JUL-2015, entry version 102.
DE   RecName: Full=DNA gyrase subunit B {ECO:0000255|HAMAP-Rule:MF_01898};
DE            EC=5.99.1.3 {ECO:0000255|HAMAP-Rule:MF_01898};
GN   Name=gyrB {ECO:0000255|HAMAP-Rule:MF_01898};
GN   Synonyms=acrB, himB, hisU, nalC, parA, pcbA;
GN   OrderedLocusNames=b3699, JW5625;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=3020376; DOI=10.1007/BF00331012;
RA   Yamagishi J., Yoshida H., Yamayoshi M., Nakamura S.;
RT   "Nalidixic acid-resistant mutations of the gyrB gene of Escherichia
RT   coli.";
RL   Mol. Gen. Genet. 204:367-373(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=3029692; DOI=10.1093/nar/15.2.771;
RA   Adachi T., Mizuuchi M., Robinson E.A., Appella E., O'Dea M.H.,
RA   Gellert M., Mizuuchi K.;
RT   "DNA sequence of the E. coli gyrB gene: application of a new
RT   sequencing strategy.";
RL   Nucleic Acids Res. 15:771-784(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12 / N2879;
RX   PubMed=9148951; DOI=10.1074/jbc.272.20.13302;
RA   Funatsuki K., Tanaka R., Inagaki S., Konno H., Katoh K., Nakamura H.;
RT   "acrB mutation located at carboxyl-terminal region of gyrase B subunit
RT   reduces DNA binding of DNA gyrase.";
RL   J. Biol. Chem. 272:13302-13308(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=7686882; DOI=10.1006/geno.1993.1230;
RA   Burland V.D., Plunkett G. III, Daniels D.L., Blattner F.R.;
RT   "DNA sequence and analysis of 136 kilobases of the Escherichia coli
RT   genome: organizational symmetry around the origin of replication.";
RL   Genomics 16:551-561(1993).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [6]
RP   SEQUENCE REVISION TO 385.
RX   PubMed=16397293; DOI=10.1093/nar/gkj405;
RA   Riley M., Abe T., Arnaud M.B., Berlyn M.K.B., Blattner F.R.,
RA   Chaudhuri R.R., Glasner J.D., Horiuchi T., Keseler I.M., Kosuge T.,
RA   Mori H., Perna N.T., Plunkett G. III, Rudd K.E., Serres M.H.,
RA   Thomas G.H., Thomson N.R., Wishart D., Wanner B.L.;
RT   "Escherichia coli K-12: a cooperatively developed annotation snapshot
RT   -- 2005.";
RL   Nucleic Acids Res. 34:1-9(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-106.
RC   STRAIN=K12;
RX   PubMed=6089112; DOI=10.1093/nar/12.16.6389;
RA   Adachi T., Mizuuchi K., Menzel R., Gellert M.;
RT   "DNA sequence and transcription of the region upstream of the E. coli
RT   gyrB gene.";
RL   Nucleic Acids Res. 12:6389-6395(1984).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-22.
RX   PubMed=3029031;
RA   Menzel R., Gellert M.;
RT   "Fusions of the Escherichia coli gyrA and gyrB control regions to the
RT   galactokinase gene are inducible by coumermycin treatment.";
RL   J. Bacteriol. 169:1272-1278(1987).
RN   [10]
RP   PROTEIN SEQUENCE OF 93-129.
RX   PubMed=2174443;
RA   Tamura J.K., Gellert M.;
RT   "Characterization of the ATP binding site on Escherichia coli DNA
RT   gyrase. Affinity labeling of Lys-103 and Lys-110 of the B subunit by
RT   pyridoxal 5'-diphospho-5'-adenosine.";
RL   J. Biol. Chem. 265:21342-21349(1990).
RN   [11]
RP   MUTANTS B17 RESISTANT.
RX   PubMed=1846808;
RA   Vizan J.L., Hernandez-Chico C., del Castillo I., Moreno F.;
RT   "The peptide antibiotic microcin B17 induces double-strand cleavage of
RT   DNA mediated by E. coli DNA gyrase.";
RL   EMBO J. 10:467-476(1991).
RN   [12]
RP   IDENTIFICATION BY 2D-GEL.
RX   PubMed=9298644; DOI=10.1002/elps.1150180805;
RA   VanBogelen R.A., Abshire K.Z., Moldover B., Olson E.R.,
RA   Neidhardt F.C.;
RT   "Escherichia coli proteome analysis using the gene-protein database.";
RL   Electrophoresis 18:1243-1251(1997).
RN   [13]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, SUBUNIT, AND MUTAGENESIS OF
RP   GLU-424; ASP-498; ASP-500 AND ASP-502.
RX   PubMed=12051843; DOI=10.1016/S0022-2836(02)00049-9;
RA   Noble C.G., Maxwell A.;
RT   "The role of GyrB in the DNA cleavage-religation reaction of DNA
RT   gyrase: a proposed two metal-ion mechanism.";
RL   J. Mol. Biol. 318:361-371(2002).
RN   [14]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, AND SUBUNIT.
RX   PubMed=18642932; DOI=10.1021/bi800480j;
RA   Sissi C., Chemello A., Vazquez E., Mitchenall L.A., Maxwell A.,
RA   Palumbo M.;
RT   "DNA gyrase requires DNA for effective two-site coordination of
RT   divalent metal ions: further insight into the mechanism of enzyme
RT   action.";
RL   Biochemistry 47:8538-8545(2008).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF 388-804, SUBUNIT, CATALYTIC
RP   ACTIVITY, AND FUNCTION.
RX   PubMed=20675723; DOI=10.1093/nar/gkq665;
RA   Schoeffler A.J., May A.P., Berger J.M.;
RT   "A domain insertion in Escherichia coli GyrB adopts a novel fold that
RT   plays a critical role in gyrase function.";
RL   Nucleic Acids Res. 38:7830-7844(2010).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 1-220, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=22731783; DOI=10.1021/jm300395d;
RA   Brvar M., Perdih A., Renko M., Anderluh G., Turk D., Solmajer T.;
RT   "Structure-based discovery of substituted 4,5'-bithiazoles as novel
RT   DNA gyrase inhibitors.";
RL   J. Med. Chem. 55:6413-6426(2012).
RN   [17]
RP   VARIANTS QUINOLONE-RESISTANT.
RC   STRAIN=K16;
RX   PubMed=1656869; DOI=10.1128/AAC.35.8.1647;
RA   Yoshida H., Bogaki M., Nakamura M., Yamanaka L.M., Nakamura S.;
RT   "Quinolone resistance-determining region in the DNA gyrase gyrB gene
RT   of Escherichia coli.";
RL   Antimicrob. Agents Chemother. 35:1647-1650(1991).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 1-393.
RX   PubMed=1646964; DOI=10.1038/351624a0;
RA   Wigley D.B., Davies G.J., Dodson E.J., Maxwell A., Dodson G.;
RT   "Crystal structure of an N-terminal fragment of the DNA gyrase B
RT   protein.";
RL   Nature 351:624-629(1991).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1-221 OF MUTANT HIS-136.
RX   PubMed=9245398; DOI=10.1021/bi970294+;
RA   Holdgate G.A., Tunnicliffe A., Ward W.H., Weston S.A., Rosenbrock G.,
RA   Barth P.T., Taylor I.W., Pauptit R.A., Timms D.;
RT   "The entropic penalty of ordered water accounts for weaker binding of
RT   the antibiotic novobiocin to a resistant mutant of DNA gyrase: a
RT   thermodynamic and crystallographic study.";
RL   Biochemistry 36:9663-9673(1997).
CC   -!- FUNCTION: DNA gyrase negatively supercoils closed circular double-
CC       stranded DNA in an ATP-dependent manner and also catalyzes the
CC       interconversion of other topological isomers of double-stranded
CC       DNA rings, including catenanes and knotted rings.
CC       {ECO:0000255|HAMAP-Rule:MF_01898, ECO:0000269|PubMed:12051843,
CC       ECO:0000269|PubMed:18642932, ECO:0000269|PubMed:20675723}.
CC   -!- CATALYTIC ACTIVITY: ATP-dependent breakage, passage and rejoining
CC       of double-stranded DNA. {ECO:0000255|HAMAP-Rule:MF_01898,
CC       ECO:0000269|PubMed:12051843, ECO:0000269|PubMed:18642932,
CC       ECO:0000269|PubMed:20675723, ECO:0000269|PubMed:22731783}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01898,
CC         ECO:0000269|PubMed:12051843, ECO:0000269|PubMed:18642932};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01898,
CC         ECO:0000269|PubMed:12051843, ECO:0000269|PubMed:18642932};
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01898,
CC         ECO:0000269|PubMed:12051843, ECO:0000269|PubMed:18642932};
CC       Note=Binds two Mg(2+) per subunit. The magnesium ions form salt
CC       bridges with both the protein and the DNA. Can also accept other
CC       divalent metal cations, such as Mn(2+) or Ca(2+).
CC       {ECO:0000255|HAMAP-Rule:MF_01898, ECO:0000269|PubMed:12051843,
CC       ECO:0000269|PubMed:18642932};
CC   -!- ENZYME REGULATION: Target of two classes of inhibitors, coumarins
CC       and quinolones. Coumarins bind to GyrB and are competitive
CC       inhibitors with respect to ATP. Quinolones bind DNA gyrase when
CC       the enzyme is complexed with DNA and trap the enzyme in a covalent
CC       reaction intermediate with DNA.
CC   -!- SUBUNIT: Heterotetramer, composed of two GyrA and two GyrB chains.
CC       Within the heterotetramer, GyrA contains the active site tyrosine
CC       that forms a covalent intermediate with the DNA, while GyrB
CC       contributes the cofactor binding sites and catalyzes ATP
CC       hydrolysis. {ECO:0000255|HAMAP-Rule:MF_01898,
CC       ECO:0000269|PubMed:12051843, ECO:0000269|PubMed:18642932,
CC       ECO:0000269|PubMed:20675723}.
CC   -!- INTERACTION:
CC       P0AES4:gyrA; NbExp=5; IntAct=EBI-541911, EBI-547129;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_01898}.
CC   -!- SIMILARITY: Belongs to the type II topoisomerase family.
CC       {ECO:0000255|HAMAP-Rule:MF_01898}.
CC   -!- SIMILARITY: Contains 1 Toprim domain. {ECO:0000255|HAMAP-
CC       Rule:MF_01898}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X04341; CAA27871.1; -; Genomic_DNA.
DR   EMBL; D87842; BAA20341.1; -; Genomic_DNA.
DR   EMBL; L10328; AAA62050.1; -; Genomic_DNA.
DR   EMBL; U00096; AAT48201.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77595.1; -; Genomic_DNA.
DR   EMBL; M15548; AAA23949.1; -; Genomic_DNA.
DR   PIR; D65172; ISECTB.
DR   RefSeq; WP_000072067.1; NZ_CP010445.1.
DR   RefSeq; YP_026241.1; NC_000913.3.
DR   PDB; 1AJ6; X-ray; 2.30 A; A=2-220.
DR   PDB; 1EI1; X-ray; 2.30 A; A/B=6-392.
DR   PDB; 1KZN; X-ray; 2.30 A; A=15-219.
DR   PDB; 3G7E; X-ray; 2.20 A; A=15-217.
DR   PDB; 3NUH; X-ray; 3.10 A; B=389-804.
DR   PDB; 4DUH; X-ray; 1.50 A; A/B=1-220.
DR   PDB; 4HYP; X-ray; 2.60 A; A/B/C/D=15-220.
DR   PDB; 4KFG; X-ray; 1.60 A; A/B=15-220.
DR   PDB; 4PRV; X-ray; 2.00 A; A=2-392.
DR   PDB; 4PRX; X-ray; 1.80 A; A=2-392.
DR   PDB; 4PU9; X-ray; 2.40 A; A=2-392.
DR   PDB; 4WUB; X-ray; 1.75 A; A=2-393.
DR   PDB; 4WUC; X-ray; 1.90 A; A=2-393.
DR   PDB; 4WUD; X-ray; 1.95 A; A=2-393.
DR   PDB; 4XTJ; X-ray; 1.92 A; A=2-392.
DR   PDBsum; 1AJ6; -.
DR   PDBsum; 1EI1; -.
DR   PDBsum; 1KZN; -.
DR   PDBsum; 3G7E; -.
DR   PDBsum; 3NUH; -.
DR   PDBsum; 4DUH; -.
DR   PDBsum; 4HYP; -.
DR   PDBsum; 4KFG; -.
DR   PDBsum; 4PRV; -.
DR   PDBsum; 4PRX; -.
DR   PDBsum; 4PU9; -.
DR   PDBsum; 4WUB; -.
DR   PDBsum; 4WUC; -.
DR   PDBsum; 4WUD; -.
DR   PDBsum; 4XTJ; -.
DR   ProteinModelPortal; P0AES6; -.
DR   SMR; P0AES6; 10-392, 406-783.
DR   DIP; DIP-48005N; -.
DR   IntAct; P0AES6; 18.
DR   STRING; 511145.b3699; -.
DR   BindingDB; P0AES6; -.
DR   ChEMBL; CHEMBL2311224; -.
DR   DrugBank; DB00817; Rosoxacin.
DR   PaxDb; P0AES6; -.
DR   PRIDE; P0AES6; -.
DR   EnsemblBacteria; AAT48201; AAT48201; b3699.
DR   EnsemblBacteria; BAE77595; BAE77595; BAE77595.
DR   GeneID; 948211; -.
DR   KEGG; eco:b3699; -.
DR   PATRIC; 32122895; VBIEscCol129921_3823.
DR   EchoBASE; EB0419; -.
DR   EcoGene; EG10424; gyrB.
DR   eggNOG; COG0187; -.
DR   HOGENOM; HOG000075155; -.
DR   InParanoid; P0AES6; -.
DR   KO; K02470; -.
DR   OMA; NINTREG; -.
DR   OrthoDB; EOG6P334W; -.
DR   PhylomeDB; P0AES6; -.
DR   BioCyc; EcoCyc:EG10424-MONOMER; -.
DR   BioCyc; ECOL316407:JW5625-MONOMER; -.
DR   BioCyc; MetaCyc:EG10424-MONOMER; -.
DR   BRENDA; 5.99.1.3; 2026.
DR   EvolutionaryTrace; P0AES6; -.
DR   PRO; PR:P0AES6; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005694; C:chromosome; IEA:InterPro.
DR   GO; GO:0005737; C:cytoplasm; IDA:EcoliWiki.
DR   GO; GO:0009330; C:DNA topoisomerase complex (ATP-hydrolyzing); IDA:EcoliWiki.
DR   GO; GO:0009295; C:nucleoid; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IDA:EcoliWiki.
DR   GO; GO:0003677; F:DNA binding; IDA:EcoliWiki.
DR   GO; GO:0003918; F:DNA topoisomerase type II (ATP-hydrolyzing) activity; IDA:EcoliWiki.
DR   GO; GO:0008094; F:DNA-dependent ATPase activity; IDA:EcoliWiki.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:UniProtKB-HAMAP.
DR   GO; GO:0007059; P:chromosome segregation; IBA:GO_Central.
DR   GO; GO:0006265; P:DNA topological change; IMP:EcoliWiki.
DR   GO; GO:0006268; P:DNA unwinding involved in DNA replication; IBA:GO_Central.
DR   GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.
DR   GO; GO:0042493; P:response to drug; IDA:EcoliWiki.
DR   GO; GO:0006351; P:transcription, DNA-templated; IMP:EcoliWiki.
DR   Gene3D; 3.30.230.10; -; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   Gene3D; 3.40.50.670; -; 2.
DR   HAMAP; MF_01898; GyrB; 1.
DR   InterPro; IPR002288; DNA_gyrase_B_C.
DR   InterPro; IPR011557; GyrB.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   InterPro; IPR014721; Ribosomal_S5_D2-typ_fold_subgr.
DR   InterPro; IPR001241; Topo_IIA.
DR   InterPro; IPR013760; Topo_IIA-like_dom.
DR   InterPro; IPR013506; Topo_IIA_bsu_dom2.
DR   InterPro; IPR013759; Topo_IIA_cen_dom.
DR   InterPro; IPR018522; TopoIIA_CS.
DR   InterPro; IPR006171; Toprim_domain.
DR   Pfam; PF00204; DNA_gyraseB; 1.
DR   Pfam; PF00986; DNA_gyraseB_C; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF01751; Toprim; 1.
DR   PRINTS; PR00418; TPI2FAMILY.
DR   SMART; SM00387; HATPase_c; 1.
DR   SMART; SM00433; TOP2c; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   SUPFAM; SSF56719; SSF56719; 2.
DR   TIGRFAMs; TIGR01059; gyrB; 1.
DR   PROSITE; PS00177; TOPOISOMERASE_II; 1.
DR   PROSITE; PS50880; TOPRIM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic resistance; ATP-binding; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; DNA-binding; Isomerase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Reference proteome;
KW   Topoisomerase.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    804       DNA gyrase subunit B.
FT                                /FTId=PRO_0000145309.
FT   DOMAIN      418    533       Toprim. {ECO:0000255|HAMAP-
FT                                Rule:MF_01898}.
FT   METAL       424    424       Magnesium 1; catalytic.
FT                                {ECO:0000255|HAMAP-Rule:MF_01898}.
FT   METAL       498    498       Magnesium 1; catalytic.
FT                                {ECO:0000255|HAMAP-Rule:MF_01898}.
FT   METAL       498    498       Magnesium 2. {ECO:0000255|HAMAP-
FT                                Rule:MF_01898}.
FT   METAL       500    500       Magnesium 2. {ECO:0000255|HAMAP-
FT                                Rule:MF_01898}.
FT   SITE        449    449       Interaction with DNA. {ECO:0000255|HAMAP-
FT                                Rule:MF_01898}.
FT   SITE        452    452       Interaction with DNA. {ECO:0000255|HAMAP-
FT                                Rule:MF_01898}.
FT   VARIANT     426    426       D -> N (in nal-24, nal-102, nal-103, nal-
FT                                107, nal-108, nal-111, nal-114, en-2 and
FT                                en-5 mutants; resistant to nalidixic acid
FT                                and to enoxacin).
FT   VARIANT     447    447       K -> E (in nal-31, nal-109, nal-115 and
FT                                nal-120 mutants; resistant to nalidixic
FT                                acid).
FT   VARIANT     751    751       W -> R (in B17 resistant mutant).
FT   VARIANT     759    760       SR -> RC (in acriflavine susceptible
FT                                mutant).
FT   MUTAGEN     424    424       E->A,Q: Strongly reduced activity
FT                                regarding both DNA supercoiling and
FT                                relaxation. Reduces ATP hydrolysis in
FT                                response to DNA binding, but has only
FT                                minor effect on the basal rate of ATP
FT                                hydrolysis.
FT                                {ECO:0000269|PubMed:12051843}.
FT   MUTAGEN     498    498       D->A,N: Strongly reduced activity
FT                                regarding both DNA supercoiling and
FT                                relaxation. Reduces ATP hydrolysis in
FT                                response to DNA binding, but has only
FT                                minor effect on the basal rate of ATP
FT                                hydrolysis.
FT                                {ECO:0000269|PubMed:12051843}.
FT   MUTAGEN     500    500       D->A: Strongly reduced activity regarding
FT                                both DNA supercoiling and relaxation.
FT                                Reduces ATP hydrolysis in response to DNA
FT                                binding, but has only minor effect on the
FT                                basal rate of ATP hydrolysis.
FT                                {ECO:0000269|PubMed:12051843}.
FT   MUTAGEN     502    502       D->A: Strongly reduced activity regarding
FT                                both DNA supercoiling and relaxation.
FT                                Reduces ATP hydrolysis in response to DNA
FT                                binding, but has only minor effect on the
FT                                basal rate of ATP hydrolysis.
FT                                {ECO:0000269|PubMed:12051843}.
FT   CONFLICT    385    385       A -> P (in Ref. 4; AAA62050).
FT                                {ECO:0000305}.
FT   CONFLICT    436    436       R -> G (in Ref. 3; BAA20341).
FT                                {ECO:0000305}.
FT   HELIX         7      9       {ECO:0000244|PDB:4WUB}.
FT   HELIX        16     21       {ECO:0000244|PDB:4DUH}.
FT   HELIX        24     27       {ECO:0000244|PDB:4DUH}.
FT   STRAND       30     33       {ECO:0000244|PDB:4DUH}.
FT   HELIX        34     53       {ECO:0000244|PDB:4DUH}.
FT   STRAND       58     63       {ECO:0000244|PDB:4DUH}.
FT   TURN         65     67       {ECO:0000244|PDB:1AJ6}.
FT   STRAND       69     73       {ECO:0000244|PDB:4DUH}.
FT   STRAND       81     83       {ECO:0000244|PDB:4DUH}.
FT   TURN         84     87       {ECO:0000244|PDB:4DUH}.
FT   HELIX        90     96       {ECO:0000244|PDB:4DUH}.
FT   TURN         98    101       {ECO:0000244|PDB:1AJ6}.
FT   STRAND      104    108       {ECO:0000244|PDB:4WUB}.
FT   STRAND      113    115       {ECO:0000244|PDB:4HYP}.
FT   HELIX       120    125       {ECO:0000244|PDB:4DUH}.
FT   STRAND      127    136       {ECO:0000244|PDB:4DUH}.
FT   STRAND      139    146       {ECO:0000244|PDB:4DUH}.
FT   STRAND      149    153       {ECO:0000244|PDB:4DUH}.
FT   STRAND      155    159       {ECO:0000244|PDB:4DUH}.
FT   STRAND      164    171       {ECO:0000244|PDB:4DUH}.
FT   TURN        173    175       {ECO:0000244|PDB:4DUH}.
FT   HELIX       184    197       {ECO:0000244|PDB:4DUH}.
FT   TURN        198    200       {ECO:0000244|PDB:4KFG}.
FT   STRAND      201    207       {ECO:0000244|PDB:4DUH}.
FT   TURN        208    210       {ECO:0000244|PDB:4DUH}.
FT   STRAND      213    216       {ECO:0000244|PDB:4DUH}.
FT   HELIX       221    230       {ECO:0000244|PDB:4WUB}.
FT   STRAND      231    233       {ECO:0000244|PDB:4PU9}.
FT   STRAND      235    238       {ECO:0000244|PDB:4WUB}.
FT   STRAND      241    247       {ECO:0000244|PDB:4WUB}.
FT   STRAND      250    262       {ECO:0000244|PDB:4WUB}.
FT   STRAND      265    270       {ECO:0000244|PDB:4WUB}.
FT   HELIX       280    299       {ECO:0000244|PDB:4WUB}.
FT   HELIX       302    306       {ECO:0000244|PDB:1EI1}.
FT   HELIX       312    316       {ECO:0000244|PDB:4WUB}.
FT   STRAND      319    326       {ECO:0000244|PDB:4WUB}.
FT   STRAND      332    334       {ECO:0000244|PDB:4WUB}.
FT   HELIX       343    363       {ECO:0000244|PDB:4WUB}.
FT   HELIX       365    391       {ECO:0000244|PDB:4WUB}.
FT   STRAND      419    424       {ECO:0000244|PDB:3NUH}.
FT   HELIX       425    435       {ECO:0000244|PDB:3NUH}.
FT   TURN        438    440       {ECO:0000244|PDB:3NUH}.
FT   STRAND      441    446       {ECO:0000244|PDB:3NUH}.
FT   HELIX       465    474       {ECO:0000244|PDB:3NUH}.
FT   STRAND      491    495       {ECO:0000244|PDB:3NUH}.
FT   TURN        501    504       {ECO:0000244|PDB:3NUH}.
FT   HELIX       505    517       {ECO:0000244|PDB:3NUH}.
FT   HELIX       519    523       {ECO:0000244|PDB:3NUH}.
FT   STRAND      527    530       {ECO:0000244|PDB:3NUH}.
FT   STRAND      534    539       {ECO:0000244|PDB:3NUH}.
FT   STRAND      542    546       {ECO:0000244|PDB:3NUH}.
FT   HELIX       549    561       {ECO:0000244|PDB:3NUH}.
FT   STRAND      564    571       {ECO:0000244|PDB:3NUH}.
FT   STRAND      573    576       {ECO:0000244|PDB:3NUH}.
FT   HELIX       577    596       {ECO:0000244|PDB:3NUH}.
FT   TURN        597    600       {ECO:0000244|PDB:3NUH}.
FT   HELIX       603    611       {ECO:0000244|PDB:3NUH}.
FT   HELIX       617    621       {ECO:0000244|PDB:3NUH}.
FT   HELIX       623    640       {ECO:0000244|PDB:3NUH}.
FT   STRAND      646    653       {ECO:0000244|PDB:3NUH}.
FT   STRAND      660    667       {ECO:0000244|PDB:3NUH}.
FT   STRAND      669    676       {ECO:0000244|PDB:3NUH}.
FT   HELIX       679    683       {ECO:0000244|PDB:3NUH}.
FT   HELIX       685    699       {ECO:0000244|PDB:3NUH}.
FT   TURN        700    703       {ECO:0000244|PDB:3NUH}.
FT   STRAND      704    711       {ECO:0000244|PDB:3NUH}.
FT   STRAND      713    718       {ECO:0000244|PDB:3NUH}.
FT   HELIX       719    730       {ECO:0000244|PDB:3NUH}.
FT   TURN        731    733       {ECO:0000244|PDB:3NUH}.
FT   STRAND      735    738       {ECO:0000244|PDB:3NUH}.
FT   HELIX       742    744       {ECO:0000244|PDB:3NUH}.
FT   HELIX       747    754       {ECO:0000244|PDB:3NUH}.
FT   TURN        757    759       {ECO:0000244|PDB:3NUH}.
FT   STRAND      762    764       {ECO:0000244|PDB:3NUH}.
FT   HELIX       767    780       {ECO:0000244|PDB:3NUH}.
SQ   SEQUENCE   804 AA;  89950 MW;  D831B95FFB3A7EE3 CRC64;
     MSNSYDSSSI KVLKGLDAVR KRPGMYIGDT DDGTGLHHMV FEVVDNAIDE ALAGHCKEII
     VTIHADNSVS VQDDGRGIPT GIHPEEGVSA AEVIMTVLHA GGKFDDNSYK VSGGLHGVGV
     SVVNALSQKL ELVIQREGKI HRQIYEHGVP QAPLAVTGET EKTGTMVRFW PSLETFTNVT
     EFEYEILAKR LRELSFLNSG VSIRLRDKRD GKEDHFHYEG GIKAFVEYLN KNKTPIHPNI
     FYFSTEKDGI GVEVALQWND GFQENIYCFT NNIPQRDGGT HLAGFRAAMT RTLNAYMDKE
     GYSKKAKVSA TGDDAREGLI AVVSVKVPDP KFSSQTKDKL VSSEVKSAVE QQMNELLAEY
     LLENPTDAKI VVGKIIDAAR AREAARRARE MTRRKGALDL AGLPGKLADC QERDPALSEL
     YLVEGDSAGG SAKQGRNRKN QAILPLKGKI LNVEKARFDK MLSSQEVATL ITALGCGIGR
     DEYNPDKLRY HSIIIMTDAD VDGSHIRTLL LTFFYRQMPE IVERGHVYIA QPPLYKVKKG
     KQEQYIKDDE AMDQYQISIA LDGATLHTNA SAPALAGEAL EKLVSEYNAT QKMINRMERR
     YPKAMLKELI YQPTLTEADL SDEQTVTRWV NALVSELNDK EQHGSQWKFD VHTNAEQNLF
     EPIVRVRTHG VDTDYPLDHE FITGGEYRRI CTLGEKLRGL LEEDAFIERG ERRQPVASFE
     QALDWLVKES RRGLSIQRYK GLGEMNPEQL WETTMDPESR RMLRVTVKDA IAADQLFTTL
     MGDAVEPRRA FIEENALKAA NIDI
//
